Interleukin-2 (IL2) fused to ricin B chain (RTB) with modifibeen fused to either IL2 or antibody Fv anti-IL2R peptides. [3] [4] [5] [6][7][8][9][10] cations of amino acid residues in each of three galactose-bindAll reagents showed potent selective cytotoxicities in vitro, in ing subdomains (1␣, 1␤ and 2␥) was expressed in insect cells, some cases, in vivo. Many patients with hematopoietic malignancies have incomWe chose an alternative strategy for producing biologically plete responses to chemoradiotherapy and die from progressactive ricin fusion molecules. We fused oligohistidine tag or ive disease. Patients' leukemic blasts may develop multiple IL2 to RTB and reassociated the fusion with RTA. 17,18 Both drug resistance phenotypes and normal tissue toxicities may ligand specificity (Ni 2+ or IL2R) and heterodimer cytotoxic limit dose escalation. Novel therapeutic modalities with minipotency were maintained. Because we used the holotoxin mal toxicities and no cross-resistance with current cytotoxic in our construction, we needed to identify and modify treatments are needed.
RTA fusions yielded nontoxic molecules. Subsequent efforts to introduce a diphtheria toxin loop peptide or factor Xa recognition sequence between IL2 and RTA did not yield Introduction disulfide-linked molecules and were noncytotoxic to IL2R bearing cells. 16 Many patients with hematopoietic malignancies have incomWe chose an alternative strategy for producing biologically plete responses to chemoradiotherapy and die from progressactive ricin fusion molecules. We fused oligohistidine tag or ive disease. Patients' leukemic blasts may develop multiple IL2 to RTB and reassociated the fusion with RTA. 17, 18 Both drug resistance phenotypes and normal tissue toxicities may ligand specificity (Ni 2+ or IL2R) and heterodimer cytotoxic limit dose escalation. Novel therapeutic modalities with minipotency were maintained. Because we used the holotoxin mal toxicities and no cross-resistance with current cytotoxic in our construction, we needed to identify and modify treatments are needed.
normal tissue binding sites on ricin. Alterations were made One such class of drugs are fusion toxins which are hybrid in amino acid residues in RTB subdomains 1␣ and 2␥, but proteins composed of peptide ligands reactive with malignant persistent sugar and cell binding and cell cytotoxicity were cells (antibody fragments or cytokines) fused to polypeptide observed. [19] [20] [21] When IL2 was fused to double lectin-site toxins (diphtheria toxin, Pseudomonas exotoxin or ricin). The mutant RTB, the reassociated heterodimer displayed reduced toxin-ligand-receptor complex internalizes into intracellular compartments from which the catalytic domain of the toxin but continued normal tissue binding and toxicity. 22 translocates to the cytosol and inactivates protein synthesis. We recently confirmed a third lectin site in RTB subdomain The target for several leukemia-directed fusion toxins has 1␤ and reduced its sugar binding affinity by the amino acid been the IL2 receptor (IL2R). IL2R is a heterotrimeric glycosubstitution Tyr-78 to histidine (unpublished data). The tripleprotein complex on the cell membrane with a 55 kDa ␣ subsite mutant had 10-to 20-fold lower galactoside avidity and unit, a 75 kDa ␤ subunit and a 64 kDa ␥ subunit. 1 The only showed similar reduction in cell sensitivity to heterodimer. normal human tissues expressing IL2R␣ and IL2R␤ are actiThree groups of investigators have chemically or genetically vated T cells, B cells, LGL cells and monocytes and some liver modified lectin sites on ricin and used covalently attached Kupffer cells, lung macrophages and skin Langerhans' cells. A ligands to study cell intoxication. [23] [24] [25] In each case, reductions variety of hematologic neoplasms may show high affinity IL2R in lectin function led to profound decreases in cytotoxic expression including hairy cell leukemia, adult T cell leukepotency. We chose to test the role of intracellular galactose mia, and a fraction of cutaneous T cell lymphomas and B cell binding in ricin intoxication by fusing IL2 to triple-site mutant chronic lymphocytic leukemias.
Materials and methods
sodium azide, and 25 mM lactose (NTEAL), ultracentrifuged at 100 000 g for 1 h, and bound and eluted from a P2 monoclonal antibody-acrylamide matrix as previously described. 26 Construction of plasmid P2 is an anti-RTB monoclonal antibody. The affinity matrix was prepared using Ultralink azlactone functionality bis-acrylSite-specific mutagenesis was performed on single-stranded pUC119-RTB[W37S/Y248H]DNA using the Sculptor in vitro amide following the recommendations of the manufacturer (Pierce, Rockford, IL, USA). Recombinant protein was mutagenesis kit (Amersham, Arlington Heights, IL, USA) as previously described. 19 The aromatic ring residue Tyr-78 in absorbed to the column in NTEAL, washed with 0.5 M NaCl, 25 mM Tris pH 9, 1 mM EDTA, 0.1% Tween 20, 0.02% the 1␤ subdomain was changed to histidine to reduce van P-dCTP labeled RTB DNA as previously described. 26 Positive wells were identified and nitrocellulose, blocked with 10% Carnation's nonfat dry milk/0.1% bovine serum albumin (BSA)/0.1% Tween 20, supernatants reassayed by limiting dilution until all wells up to 10 −8 dilution were positive. Two rounds of selection were washed with PBS plus 0.05% Tween 20, reacted with either 1:400 rabbit antibody to ricin or 1:100 mouse monoclonal required. Recombinant virus in the supernatant was then amplified by infection Sf9 cells at a multiplicity of infection antibody to IL2 (5 g/ml), rewashed, incubated with alkaline phosphatase-conjugated goat anti-(rabbit IgG) or anti-(mouse (MOI) of 0.1, followed by collection of day 7 supernatants. Protein purification shaken overnight at room temperature. The reaction mixture was then analyzed by a modified ricin ELISA previously Media supernatants were adjusted to 0.01% sodium azide and maintained through all purification steps at 4°C. The superdescribed. 22 Reassociated mixtures were also analyzed by non-reducing SDS/PAGE followed by immunoblots with P2 natants were concentrated 15-fold by vacuum dialysis, centrifuged at 3000 g for 10 min to remove precipitate, dialyzed and P10 anti-RTB monoclonal antibodies (10 g/ml each), monoclonal antibody to IL2 (5 g/ml), or monoclonal antiagainst 50 mM NaCl, 25 mM Tris pH 8, 1 mM EDTA, 0.01% body ␣BR12 to RTA (10 g/ml). Densitometric scanning with free RTA concentration (2 × 10 −9 M-2 × 10 −13 M) should not produce cytotoxicity. the automatic image analysis system was done to quantify the shift of immunoreactive material from 50 kDa to 80 kDa.
Blocking of cytotoxicity with IL2 or lactose Lectin activity of heterodimer HUT102 cells (1.5 × 10 4 ) were placed in sterile Eppendorf Asialofetuin (1 g/ml) was bound to Costar (Cambridge, MA, tubes at 4°C in 100 l leucine-poor RPMI 1640 + 10% USA) EIA plate wells and an ELISA was performed as dialyzed fetal calf serum with or without 20 g/ml IL2 or previously detailed with samples of ADP-IL2-ADP-60 mM ␣-lactose. Dilutions of IL2-lectin site-modified ricin RTB[W37S/Y248H/Y78H]-RTA and castor bean ricin. 22 and ricin at varying concentrations were added in identical Briefly, the asialofetuin-coated wells were washed with PBS medium with or without IL2 or lactose and incubated at 4°C plus 0.1% Tween 20, blocked with 3% BSA, rewashed and for 30 min. Cells were pelleted at 2000 g for 5 min, washed incubated with 12 different concentrations of samples in EXonce with leucine-poor RPMI 1640 + 10% dialyzed fetal calf CELL400, rewashed and reacted with 100 l of biotinylated serum, resuspended in 150 l of the same medium and incu-␣BR12 monoclonal anti-RTA antibody, rewashed and incubated at 37°C in 5% CO 2 for 24 h. 3 H-leucine was added as bated with streptavidin-alkaline phosphatase, washed again above and, 4 h later, cells were harvested with a Skatron cell and developed with p-nitrophenylphosphate in 50 mM diethaharvestor and incorporated 3 H-leucine measured in a liquid nolamine pH 9.6. Absorbance of wells was measured at scintillation counter. Blocking of selective cytotoxicity was 405 nm on a microtiter plate reader. The concentration of proestimated by comparing the ID 50 of toxins in the presence or tein giving half-maximal binding (K d ) was calculated.
absence of IL2 or lactose.
IL2 receptor binding specificity were partially purified. Peak eluant fractions contained min. The IL2R content of these cells was previously deter-186 g, 228 g and 167 g protein based on absorbance at mined by our laboratory. 27 The cells were then incubated live 280 nm. BioRad protein assay gave values of 120 g, 160 g, at 4°C. The cells were washed with 2 mg/ml BSA in PBS and and 140 g, respectively, for the three preparations, using incubated in PBS plus BSA with 1 g/ml castor bean ricin or bovine serum albumin standard. Densitometry of Coomassie-IL2-lectin-deficient ricin. The incubation was done at 4°C.
stained gels showed only a single detectable band at 50 kDa The cells were then washed with PBS and incubated with in each preparation ( Figure 1 ). However, P2 antibody ELISA ␣BR12 mouse monoclonal antibody to RTA (5 g/ml) plus showed the concentration of anti-RTB immunoreactive pro-BSA for 30 min at 4°C. The cells were then washed with PBS tein was 102 g, 49 g, and 75 g, respectively. Thus, purity and reacted with goat anti-(mouse Ig) conjugated to rhodawas between 21 and 85% based on absorbance, BioRad promine (Jackson ImmunoResearch, West Grove, PA, USA) at tein assay and densitometry of Coomassie-stained gels. 25 g/ml for 30 min at 4°C. The cells were washed again in PBS and fixed in 3.7% formaldehyde in PBS, mounted under a No. 1 coverslip in glycerol-PBS (90:10) and examined using a Zeiss (Norcross, GA, USA) axioplan epifluorescence microscope.
Cytotoxicity to mammalian cells
Measurement of protein synthesis inhibition by ricin and ADP-IL2-ADP-RTB[W37S/Y248H/Y78H]-RTA in cultured cells was done as previously described using HUT102, CEM, YT2C2, MT-1, and KB cells.
22 ADP-IL2-ADP-wild-type RTB-RTA and ADP-IL2-ADP-RTB[W37S/Y248H] prepared as described previously were also tested.
18,22 All assays were performed in triplicate. Twelve different concentrations of toxins were used. The ID 50 was the concentration of protein which inhibited protein synthesis by 50% compared with control wells without toxin. There was no purification step after heterodimer reassociation. The free RTA concentration at the highest con- Specificity for high affinity IL2 receptor was demonstrated on body to IL2 bound the hybrid molecule 20% as well as with recombinant human IL2 on a molar basis when an anti-IL2-a live cell immunofluorescence assay (Figure 4) . The IL2 fusion toxin bound to HUT102, YT2C2, MT-1 but did not bind anti-IL2 sandwich assay format was used. Since steric hindrance may prevent detection of bound IL2-RTB in such an CEM or KB cells. Binding to HUT102 cells was inhibited by IL2 but not asialofetuin. Fusion toxin binding to YT2C2 and ELISA, we repeated the assay using either anti-RTB with anti-IL2 detecting reagent or the reverse. In both cases, the assay MT-1 were 10-fold less than HUT102 cell binding consistent with the presence of lower densities of only intermediate and then showed 100% binding relative to the ELISA using P2 capture with rabbit anti-RTB detection.
low affinity receptor subunits on the former cell lines. Immunoblots demonstrated reactivity with the same 52 kDa band using anti-RTB or anti-IL2 antibodies (Figure 2a and b) . No weaker bands at lower molecular weight were observed Cell cytotoxicity with either set of antibodies suggesting the partial proteolysis found with IL2-'wild-type' RTB was not present with the lectin-deficient chimeras.
Cytotoxicities of fusion heterodimer and plant ricin for different cell lines are shown in Table 1 
Discussion
mutant RTB molecules reacted with antibodies to IL2 and RTB both by ELISA and Western blots suggestive of maintenance of at least some IL2 and RTB epitopes on the fusion molecule. Several strategies have been used to target the IL2R in patients with leukemias and lymphomas. Infusions of murine antiFurthermore, the protein was secreted into the insect cell medium, and purification was accomplished by a one-step IL2R␣ in 7/19 adult T cell leukemia (ATL) patients produced remissions lasting from 9 weeks to 3 years. 29 To enhance cliniimmunoaffinity absorption. This contrasts with the requirement for denaturation and refolding for many bacterial toxin cal efficacy, both radioisotopes and peptide toxins have been linked to anti-IL2R antibodies. Yttrium-90 was conjugated to fusion proteins 36, 37 and chemical derivatization and conjugation for immunotoxins. 38 anti-IL2R␣ and administered to 18 ATL patients yielding two complete and seven partial remissions with myelotoxicity. 30 The toxophore domain of ricin (RTA) was added by simply mixing with the IL2 triple-site mutant RTB at 10 −6 M. Extensive PE conjugated to anti-IL2R␣ produced hepatotoxicity in no responses in four ATL patients. 31 To reduce side-effects of PE ionic and hydrophobic bonds in the RTA-RTB interface promote reassociation and disulfide bond formation. 33 Our obserconjugates and improve targeting, single chain antibodies to IL2R␣ and IL2R␤ have been fused to non-cell binding PE fragvation of 80% reassociation compares favorably with the 60% reassociation for IL2-wild-type RTB-RTA, 18 55% reassociation ments and tested for cytotoxicity on fresh leukemic blasts.
7-10
Potent selective toxicity was seen in vitro. RTA was conjufor IL2-double-site mutant RTB-RTA 22 and 50% reassociation for plant RTB-RTA under identical conditions. 26 The heterodigated to anti-IL2R␣ and given intravenously to 14 Hodgkin's disease patients, and one partial remission was seen.
14,32 Vasmers were stable at high dilution (10 −12 M) suggesting formation of the disulfide bond between RTA Cys-259 and RTB cular leak syndrome (VLS) with edema, weight gain, hypoalbuminemia and dyspnea was dose-limiting. In a parallel Cys-4.
34
Binding specificity of the lectin-deficient heterodimer was approach, IL2 was fused to fragments of DT 3, 4 and given systemically to lymphoid malignancy patients. DAB 486 IL2 -condemonstrated in both ELISA and cell immunofluorescence formats. The fusion toxin displayed 0.3% binding to immobilized sisting of the first 486 amino acids of DT fused to IL2 -produced three complete remissions and eight partial remissions asialofetuin. The K d was 1.2 × 10 −7 M vs 4 × 10 −9 M for plant ricin. This weak binding compares to 1% binding among 109 patients. 5 DAB 389 IL2 -the first 389 amino acid residues of DT fused to IL2 -yielded five complete remissions
−9 M) for IL2-wild-type RTB-RTA. The low and seven partial remissions among 35 cutaneous T cell lymphoma patients. 6 Mild hepatotoxicity and VLS were observed level binding observed in the ELISA is near the limits of detection in this assay (lower limit 0.1% relative to wild-type ricin in the first cycle of treatment in some patients. Thus, results with both radioimmunoconjugates and fusion toxins showed or K d = 4 × 10 −6 M). Nevertheless, we believe the small residual binding of the 1␣, 1␤, 2␥ triple mutant fused to IL2 responses in about half of patients with receptor-positive lymphoid neoplasms. However, durable complete remissions is real and due to incomplete inactivation of one or more sites. Subdomain 1␣ mutation W37S reduced sugar binding avidity were rare suggesting the need for more potent and selective IL2R-directed therapies. Ricin protein targeted to the IL2R may four-fold, while other 1␣ subdomain mutations (K40M and K40M/N46G) yielded proteins with seven-to eight-fold provide such a more potent and selective reagent.
Synthesis of an IL2R-targeted ricin fusion protein for prereductions in asialofetuin avidity. 19 The W37S mutation was used in the IL2-triple-site mutant because of its much better clinical and clinical development requires adequate yields, simple purification, adequate stability at room temperature yields. IL2 triple-site RTB mutant-RTA bound to cells possessing and 37°C, and selective toxicity to IL2R bearing lymphocytes. 
Figure 6
Blocking experiments of IL2-lectin-deficient ricin cytotoxicity to HUT102 cells by IL2 and ␣-lactose. In each case: (s) media alone; (q) 100 mM ␣-lactose added; (v) 20 g/ml human IL2 added. Cells were exposed at the dilutions indicated for 30 min at 4°C, washed and incubated in media alone for 24 h at 37°C/5% CO 2 . Incorporation of 3 H-leucine was assayed after a 4 h incubation and compared against untreated cell incorporation. cytotoxicity of RTB[W37S/Y248H/Y78H]-RTA on mouse macrophages. The latter hypothesis requires further reduction in ricin binding which we will study by preparing additional triple-site and quadruple-site RTB mutants. Fortunately, the potent cytotoxicity of the IL2-triple-site RTB mutant-RTA is beneficial for preclinical development, and rodent toxicity studies are ongoing.
The IL2-lectin-deficient fusion toxin was selectively cytotoxic to hematopoietic neoplastic cell lines with the heterotrimeric high affinity IL2R. The molecules were less toxic to cells with intermediate or low affinity IL2R, and over 100-fold a 1000-fold difference in sensitivity between receptor positive and negative cells was observed. 42 However, subsequent preparations of purified doubly blocked ricin anti-CD19 lectin-deficient ricin conjugate again had reduced cell cytotoxicity, although cell binding and entry was mediated by immunoconjugate yielded sensitivity of receptor negative cells to anti-CD19-blocked ricin only 100-fold less than receptor non-galactoside mechanisms. If IL2R-targeted ricin behaved similarly, we would expect markedly reduced cytotoxicity for positive cells (5 nM vs 0.05 nM). 43 The difference in therapeutic window was ascribed to variations in the content of the IL2-triple-site RTB mutant-RTA. However, Kronke et al 39 and Winkler et al 40 demonstrated RTA alone conjugated to doubly blocked and triply blocked immunoconjugate in the preparations. In one study with anti-CD25-RTA, cells lacking monoclonal anti-IL2R␣ subunit antibodies yielded conjugates toxic to ATL and Hodgkin's disease cells, respectively, with the IL2R were also 100-fold less sensitive to drug. 39 The in vitro therapeutic index was not determined for another anti-IC 50 s of 2 × 10 −10 M and 6 × 10 −12 M. These previous findings suggested the fusion toxin would kill IL2R bearing cells, albeit CD25-RTA. 40 The sensitivity of cells bearing a portion of the IL2R were similar to those seen with IL2-PE40 35 but distinct with variable potency. The lectin-deficient fusion toxin was equally toxic as IL2-wild-type RTB-RTA or ricin. Thus, either from those seen with DAB 389 IL2. 27 The latter molecule fails to intoxicate low affinity IL2R␣,␥ cells perhaps due to steric intracellular galactose binding is not required for cell intoxication by ricin directed into cells by the IL2R, or the minimal effects of the N-terminal toxin moiety. As a note of caution, fresh leukemic blasts often display lower levels of IL2R␣ and residual galactose binding of the triple-site mutant has adequate avidity for the intracellular galactose-binding step.
IL2R␤ than cell lines and may show lowered sensitivity to the ricin fusion molecule. 8 We intend to test the former hypothesis by evaluating the
